MYC and neoplasm: This research demonstrated that LINC00460 promoted CRC cell immune escape by increasing the expressions of MYC, CD47 and PD-L1 in CRC cells and remodeling the CRC tumor-inhibitory immune microenvironment, thereby promoting the occurrence and development of CRC tumors.